Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET
Positron emission tomography (PET), with or without integrated computed tomography (CT), using 18F-fluorodeoxyglucose (FDG) is based on the principle of elevated glucose metabolism in malignant tumors, and its use in breast cancer patients is frequently being investigated. It has been shown useful f...
Main Authors: | B. B. Koolen, W. V. Vogel, M. J. T. F. D. Vrancken Peeters, C. E. Loo, E. J. Th. Rutgers, R. A. Valdés Olmos |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Journal of Oncology |
Online Access: | http://dx.doi.org/10.1155/2012/438647 |
Similar Items
-
Evaluation of primary breast cancers using dedicated breast PET and whole-body PET
by: Deep K. Hathi, et al.
Published: (2020-12-01) -
Texture Analysis in the Diagnosis of Primary Breast Cancer: Comparison of High-Resolution Dedicated Breast Positron Emission Tomography (dbPET) and Whole-Body PET/CT
by: Yoko Satoh, et al.
Published: (2020-12-01) -
Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
by: Alexander M Th Schmitz, et al.
Published: (2017-01-01) -
Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer
by: Mette S. van Ramshorst, et al.
Published: (2017-05-01) -
Characterisation of MRI Indeterminate Breast Lesions Using Dedicated Breast PET and Prone FDG PET-CT in Patients with Breast Cancer—A Proof-of-Concept Study
by: Anmol Malhotra, et al.
Published: (2020-09-01)